Exo Therapeutics is a small molecule drug discovery and development company with technology to address intractable pharmaceutical targets. By leveraging the company’s ExoSight platform, Exo is developing a deep pipeline of potent drug candidates that bind exosites, distal and unique binding pockets that have the potential to reprogram enzyme activity for precise and robust therapeutic effect.
The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.
Research containing Exo Therapeutics
Get data-driven expert analysis from the CB Insights Intelligence Unit.
CB Insights Intelligence Analysts have mentioned Exo Therapeutics in 1 CB Insights research brief, most recently on Jan 19, 2021.
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
Exo Therapeutics is included in 1 Expert Collection, including Biopharmaceuticals.
Companies involved in the research, development, and commercialization of chemically- or biologically-derived therapeutic & theranostic drugs. Excludes vitamins/supplements, CROs/clinical trial services.
Exo Therapeutics Web Traffic
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
Exo Therapeutics Rank